Serum prolactin levels in psoriasis and correlation with cutaneous disease activity

Clinical and Experimental Dermatology

Volumn 36, Issue 1, 2011, Pages 29-32

  Dilme Carreras E ^a   Martin Ezquerra G ^b   Sanchez Regana M ^a   Umbert Millet, P ^a  

^a HOSPITAL UNIVERSITARI SAGRAT COR   (Spain)

^b HOSPITAL DEL MAR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PROLACTIN; TACALCITOL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PSORIASIS VULGARIS; SKIN DISEASE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DERMATOLOGIC AGENTS; DIHYDROXYCHOLECALCIFEROLS; FEMALE; HUMANS; MALE; MIDDLE AGED; OINTMENTS; PROLACTIN; PSORIASIS; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78650151946     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2010.03871.x     Document Type: Article

References (24)

1. Ferrándiz C, Bordas X, García-Patos V et al. Psoriasis of early and late onset: a clinical and epidemiologic study from Spain. J Am Acad Dermatol 2002; 46: 867-73.
2. Griffiths TW, Griffiths CE, Voorhees JJ. Immunopathogenesis and immunotherapy of psoriasis. Dermatol Clin 1995; 13: 739-49.
3. Gottlieb AB, Krueger JC, Wittkowski K et al. Psoriasis as a model for T-cell-mediated disease: immunobiologic and clinical effects of treatment with multiple doses of efalizumab, an anti-CD11a antibody. Arch Dermatol 2002; 138: 591-600.
4. Bowcock AM, Berker JN. Genetics of psoriasis: the potential impact on new therapies. J Am Acad Dermatol 2003; 49: S51-6.
5. De Cid R, Volpini V, Almansy L et al. [Análisis de las regiones de predisposición a la psoriasis en la población española: evidencia de un General principal implicado en la psoriasis en la región 6p21] (in Spanish). Med Clin 2001; 117: 49-51.
6. Sánchez Regaña M, Ojeda R, Umbert P. [El impacto psicosocial de la psoriasis] (in Spanish). Actas Dermosifiliogr 2003; 94: 11-16.
7. Mowad CM, Margolis DJ, Halperin A et al. Hormonal influences on woman with psoriasis. Cutis 1998; 61: 257-60.
8. Sánchez Regaña M, Umbert P. Psoriasis in association with prolactinoma. Br J Dermatol 2000; 143: 864-7.
9. Giasuddin AS, El-Sherif AI, El-Ojali SI. Prolactin: does it have a role in the pathogenesis of psoriasis? Dermatology 1998; 197: 119-22.
10. Buskila D, Sukenik S, Shoenfeld Y. The possible role of prolactin in autoimmunity. Am J Reprod Immunol 1991; 26: 118-23.
11. Girolomoni G, Philips JT, Bergstresser PR. Prolactin stimulates proliferation of cultured human keratinocytes. J Invest Dermatol 1993; 101: 275-9.
12. Frediksson T, Petterson U. Severe psoriasis: oral therapy with a new retinoid. Dermatologica 1978; 157: 238-44.
13. Sánchez Regaña M, Catabús M, Creus L, Umbert M. Serum neopterin as an objective marker of psoriasis disease activity. Acta Derm Venereol 2000; 80: 185-7.
14. Jara LJ, Lavalle C, Fraga A et al. Prolactin, immunoregulation, and autoinmune diseases. Semin Arthritis Rheum 1991; 20: 273-84.
15. Posner BI, Kelly PA, Shiu RP, Friesen HG. Studies of insulin, growth hormone and prolactin binding. tissue distribution, species variation and characterization. Endocrinology 1972; 95: 521-31.
16. Russell DH, Kibler R, Matrisian L et al. Prolactin receptors on human T and B lymphocytes: antagonism of prolactin binding cyclosporine. J Immunol 1985; 134: 3027-31.
17. Kanda N, Watanabe S. Prolactin enhances interferon-gamma-induced production of CXC ligand 9 (CXCL9), CXCL10, and CXCL11 in human keratinocytes. Endocrinology 2007; 148: 2317-25.
18. Lavalle G, Loyo E, Paniagua R et al. Correlation study between prolactin and androgens in male patients with systemic lupus erythematosus. J Rheumatol 1987; 14: 268-72.
19. Chuang E, Molitch ME. Prolactin and autoimmune disease in humans. Acta Biomed 2007; 78 (Suppl. 1): 225-61.
20. Buskila D, Sukenik S, Holcberg G, Horowitz J. Improvement of psoriatic arthritis in a patient treated with bromocriptine for hyperprolactinaemia. J Rheumatol 1991; 18: 611-12.
21. Hedman M, Nilson D, De la Torre B. Low blood and synovial fluid levels of sulpho-conjugated steroids in rheumatoid arthritis. Clin Exp Rheumatol 1992; 10: 25-30.
22. Weber G, Neidhardt M, Frey H et al. Treatment of psoriasis with bromocriptin. Arch Dermatol Res 1981; 271: 437-9.
23. Valentino A, Fimiani M, Bilenchi R et al. [Terapia con bromocriptina e comportamento di alcuni ormoni in soggetti psoriasici] (in Italian). Boll Soc Ital Biol Sper 1984; 60: 1841-4.
24. Cooke NE. Prolactin: normal synthesis, regulation, and actions. In: Endocrinology (De Groot LJ, ed). Philadelphia: W.B. Saunders, 1989: pp 384-407.